Gene Therapy for Rare Disorders 2017 will bring together key decision makers from industry- leading pharma and biotech companies in the gene therapy space.
The potential for gene therapies is apparent, yet these drug developer organizations are telling us that they have little visibility of which CMOs, CROs and vector platform companies have the technical experience, capacity and flexibility to meet their demands.
If you have capabilities that would benefit our audience in the gene therapy space, Gene Therapy for Rare Disorders 2017 provides a unique platform to showcase your solutions, generate new business leads and source opportunities for partnerships.
Partnering with the only conference exclusively dedicated to the development of gene therapies will enable you to secure and expand your market share in this commercially expanding market.
Act now to stay ahead of the curve and seize the wealth of opportunity on offer.